Blade Therapeutics, Inc. — Form D

Blade Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-24. The offering totals $24.0M, of which $12.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Rana Rae Al-HallaqDirectorSouth San Francisco, CA
Luke Shirley EvninDirectorSouth San Francisco, CA
Lloyd B KlicksteinDirectorSouth San Francisco, CA
Wendye Rae RobbinsDirectorSouth San Francisco, CA
James B ScopaDirectorSouth San Francisco, CA
William V SlatteryDirectorSouth San Francisco, CA
Peter Shirley Van VlasselaerDirectorSouth San Francisco, CA
Cameron Shirley WheelerDirectorSouth San Francisco, CA
M. Shirley ChiangExecutive OfficerSouth San Francisco, CA
Prabha Shirley IbrahimExecutive OfficerSouth San Francisco, CA
Gary B PatouExecutive OfficerSouth San Francisco, CA
Wendye Rae RobbinsExecutive OfficerSouth San Francisco, CA
Elaine JonesDirectorSOUTH SAN FRANCISCO, CA
Luke EvninDirectorWatertown, MA
Cameron WheelerDirectorCambridge, MA
Peter Van VlasselaerDirectorNew York, NY
William SlatteryDirectorBala Cynwyd, PA
Cameron V WheelerDirectorSouth San Francisco, CA
Peter V Van VlasselaerDirectorSouth San Francisco, CA
James ScopaDirectorSan Diego, CA
Wendye RobbinsDirectorSOUTH SAN FRANCISCO, CA
Wendye RobbinsExecutive OfficerSOUTH SAN FRANCISCO, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2019-10-24D$50.0M$38.0M
2016-06-20D$45.4M$27.1M

More